Search
for
Sort by
Research 30 of 62
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Rare Case of Alopecia: Alopecia Neoplastica
- Prostaglandin E2 prevents radiotherapy-induced alopecia by attenuating transit amplifying cell apoptosis through promoting G1 arrest
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Cellular senescence in tissue repair: every cloud has a silver lining
- Oncogenic senescence: a multi-functional perspective
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Novel drugs of United States Food and Drug Administration approved in 2024
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- Hair Changes due to Drugs
- Cancer Treatments and Alopecia: A Systematic Review
- A Case Control Study to Determine the Correlation Between Serum Ferritin Levels and Chronic Telogen Effluvium in a Tertiary Hospital, Mandya
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
- Prevention and Treatment of Chemotherapy-Induced Alopecia